Amgen, Inc. (AMGN)
Current
- (-)
After Hours
Rating Performance
Rating Return
+5.33% vs
Rating Accuracy
50.0% (1 of 2*)
Rating Return
+5.33% vs
Rating Accuracy
50.0% (1 of 2*)
Rating Return
+5.33% vs
Rating Accuracy
50.0% (1 of 2*)
Rating Return
+10.29% vs
Rating Accuracy
33.33% (1 of 3*)
FV Performance
FV Accuracy
4 Hits (57.14% Hit Rate)
FV Avg. Distance
-10.87%
FV Accuracy
4 Hits (33.33% Hit Rate)
FV Avg. Distance
-16.66%
FV Accuracy
4 Hits (21.05% Hit Rate)
FV Avg. Distance
-16.66%
FV Accuracy
4 Hits (9.3% Hit Rate)
FV Avg. Distance
-7.29%
*There is a current rating on the stock that is included in these numbers based on its performance so far
About
CEO
Robert A. Bradway
Employees
23,400
Industry
Diversified Biopharmaceuticals
Sector
Healthcare
Headquarters
Thousand Oaks
Exchange
NASDAQ
Website
http://www.amgen.comSummary Stats
Market Cap
124B
Revenue
26.3B
Net Income
6.55B
EPS
$12.11
Price-to-Earnings
19.25
Price-to-Book
34.0
Debt-to-Equity
16.79
News
Analyst Ratings
Price targets projected by 23 analysts
High
$304.00
Average
$251.78
Low
$185.00
Ratings calculated by 29 analysts
Buy
13
Hold
15
Sell
1
Last Dividend
Amount
$2.13
Dividend Date
Frequency
quarterly
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q4 2022
Missed by $0.00
$4.09 +0.0%
4.09
4.36
Down 6%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--